Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Devarati Mitra
Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma
Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma Abstract Importance There is no consensus on staging and surveillance imaging for cutaneous squamous cell carcinoma (CSCC). Although imaging has been shown to affect management, broad recommendations from the National Comprehensive Cancer Network have led to variability in clinical practice.
Germline variants in cancer susceptibility genes among patients with mucosal melanoma
|
Abstract Mucosal melanoma (MM) is a rare and aggressive melanoma subtype with poor outcomes and poorly understood risk factors, including the contribution of germline pathogenic variants (PVs). In this study, 346 MM patients treated at MD Anderson Cancer Center underwent germline sequencing of 322 known cancer susceptibility genes, with PV frequencies compared to population controls (gnomAD and TOPMed) using Fisher’s exact test.
By Afsaneh Amouzegar, Xiaogang Wu, James Long, Gabriela Chen, Justin Wong, Curtis Gumbs, Jared C. Malke, Julie Simon, Jianhua Zhang, Priyadharsini Nagarajan, michael davies, Hussein Tawbi, Rodabe N. Amaria, Alexandra Ikeguchi, Shirley Y Su, Ehab Hanna, Roi Weiser, Brian K. Bednarski, Travis Sims, Devarati Mitra, Jennifer Wargo, Jeffrey E. Gershenwald, Paul Scheet, Yao Yu, Kelly Nelson, Jennifer McQuade, P. Andrew Futreal, Sabitha Prabhakaran, Latasha Little, Neus Bota, Isabella C. Glitza Oliva, Chad Huff
|
Nature
Verified
A Review of Melanoma
To the Editor As radiation oncologists specializing in skin and soft tissue malignancies, we appreciated the Review on cutaneous melanoma by Dr Joshi and colleagues.1 However, we were surprised to note that radiotherapy was not mentioned.
Discordance in acute gastrointestinal toxicity between synchrotron-based proton and linac-based electron ultra-high dose rate irradiation
Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes aDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA bThe University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, USA cHitachi Particle Engineering...
Adjuvant Radiation Therapy in Desmoplastic Melanoma: A Scoping Review
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation
Abstract Locoregional recurrence (LRR) is the predominant pattern of relapse and often the cause of death in patients with retroperitoneal sarcomas (RPS). As a result, reducing LRR is a critical objective for RPS patients. However, unlike soft tissue sarcomas (STS) of the superficial trunk and extremity where the benefits of radiation therapy (RT) are well-established, the role of RT in the retroperitoneum remains controversial.
Hypofractionated, 3-Week, Preoperative Radiotherapy for Patients With Soft Tissue Sarcomas (Hyport-Sts): A Single-Centre, Open-Label, Single-Arm, Phase 2 Trial
BACKGROUND: The standard preoperative radiotherapy regimen of 50 Gy delivered in 25 fractions for 5 weeks for soft tissue sarcomas results in excellent local control, with major wound complications occurring in approximately 35% of patients. We aimed to investigate the safety of a moderately hypofractionated, shorter regimen of radiotherapy, which could be more convenient for patients.
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT‐STS): Updated local control, late toxicities, and patient‐reported outcomes
CONFLICT OF INTEREST STATEMENT Ravin Ratan reports grants/contracts from Ayala Pharmaceuticals; personal/consulting fees from Ipsen Bioscience Inc. and SpringWorks Therapeutics; and support for other professional activities from Ayala Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc., C4 Therapeutics, and Epizyme Inc. outside the submitted work.
Nodal Radiotherapy for Anorectal Melanoma: Finding the Appropriate Time and Place
Anorectal melanoma patients with “isolated” upper pelvic nodal involvement are likely showing just the tip of the disease iceberg. 1 Therefore, we would first reach out to our medical oncology colleagues at a multidisciplinary melanoma referral center for systemic therapy options such as bio/chemotherapy, antiangiogenic agents, KIT inhibitors, or tumor-infiltrating lymphocyte therapy.
Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation
Abstract : Locoregional recurrence (LRR) is the predominant pattern of relapse and often the cause of death in patients with retroperitoneal sarcomas (RPS). As a result, reducing LRR is a critical objective for RPS patients. However, unlike soft tissue sarcomas (STS) of the superficial trunk and extremity where the benefits of radiation therapy (RT) are well-established, the role of RT in the retroperitoneum remains controversial.
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
Background The standard preoperative radiotherapy regimen of 50 Gy delivered in 25 fractions for 5 weeks for soft tissue sarcomas results in excellent local control, with major wound complications occurring in approximately 35% of patients. We aimed to investigate the safety of a moderately hypofractionated, shorter regimen of radiotherapy, which could be more convenient for patients.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Devarati
Contact Devarati, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack